1 Min Read
Nov 9 (Reuters) -
* Promius Pharma initiates phase 3 clinical trials of DFD-03 for the treatment of acne vulgaris Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.